Sharon Seiler
About Sharon Seiler
Sharon Seiler serves as the Vice President of Business Development at Roivant Sciences, a position she has held since 2014. With a background in technology management and commercialization, she previously worked at Memorial Sloan Kettering Cancer Center in various roles for over a decade.
Work at Roivant Sciences
Sharon Seiler has served as Vice President of Business Development at Roivant Sciences since 2014. In this role, she is responsible for overseeing business development initiatives and strategies within the organization. Roivant Sciences is known for its focus on innovative approaches to drug development and commercialization. Seiler's tenure at the company spans a decade, during which she has contributed to various projects and initiatives aimed at advancing the company's mission in the biopharmaceutical industry.
Previous Experience at Memorial Sloan Kettering Cancer Center
Before joining Roivant Sciences, Sharon Seiler held multiple positions at Memorial Sloan Kettering Cancer Center. She worked as a Senior Manager in Technology Management and Commercialization in the Office of Technology Development from 2011 to 2014. Prior to that, she served as a Senior Licensing Manager in the same office from 2009 to 2011. Her career at the center began as a Research Fellow at the Sloan-Kettering Institute for Cancer Research, where she worked from 1989 to 1994. These roles contributed to her expertise in technology transfer and commercialization within the healthcare sector.
Education and Expertise
Sharon Seiler holds a Bachelor of Arts degree from Princeton University, where she studied from 1978 to 1982. She furthered her education at the Massachusetts Institute of Technology, earning a Doctor of Philosophy degree between 1982 and 1989. Her academic background provides a strong foundation for her work in business development and technology management in the life sciences field.
Career Timeline
Sharon Seiler's professional journey includes significant roles spanning over three decades. She began her career as a Research Fellow at the Sloan-Kettering Institute for Cancer Research from 1989 to 1994. Following this, she transitioned to various positions at Memorial Sloan Kettering Cancer Center, where she worked for a total of five years in different capacities related to technology development and licensing. In 2014, she joined Roivant Sciences, where she has continued to build her career in business development.